Letizia Caccialupi, VP quality system excellence, and Dominika Lisikiewicz, head of global quality management systems and BPO at Aenova, explains why digital transformation in pharma starts long before the software.
Joel Pike, senior global product manager, Avantor looks at the role of excipients in enabling the shift from intravenous to subcutaneous drug delivery.
Graham Doyle, sector manager EMEA Life Sciences, Watson-Marlow Fluid Technology Solutions (WMFTS) shares what the company will be showcasing at Ilmac, in Switzerland.
At CPHI Milan, GEA launches a new approach to coating technology that removes the guesswork from formulation development and bridges the gap between R&D and commercial-scale OSD manufacturing.
Prabhakar Reddy, PhD, senior director, Pharmaceutical Science General Chapters & Complex Generics, USP discusses how complex formulations demand a new approach to quality and standardisation.
In August 2026, the European Union’s (EU's) Packaging and Packaging Waste Regulation (PPWR) took direct effect across all member states. Claudia Anzaldo and Véronique Boscher at ICON plc discuss.
Dr. Janik Kaufmann, technical sales specialist Oligonucleotides, Hongene Biotech, looks at why chemoenzymatic technologies are moving into the spotlight.
Jason Bryant, general manager of AI platforms at ArisGlobal, and Samuel Wallis, head of case processing at Bristol Myers Squibb, argue that pharmacovigilance teams need a formal measure of trust in validated AI systems.
